Uni-Bio Science Group Limited (HKG:0690)

Uni-Bio Science Group Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	102.3	168.82	54.21	129.24	98.22	83.61
Short-Term Investments	-	18.86	119.87	12.36	10.4	6.72
Cash & Short-Term Investments	102.3	187.68	174.08	141.59	108.62	90.33
Cash Growth	-47.42%	7.82%	22.94%	30.35%	20.26%	17.82%
Accounts Receivable	135.91	90.43	70.24	53.22	57.87	71.63
Other Receivables	-	-0.55	-0.79	0.59	-	-
Receivables	144.95	98.58	100.13	60.11	57.87	71.63
Inventory	45.46	37	33.78	36.39	33.85	39.71
Restricted Cash	-	11.07	10.8	-	-	-
Other Current Assets	56.56	-	-	-	-	-
Total Current Assets	349.28	334.34	318.78	238.1	200.34	201.67
Property, Plant & Equipment	185.07	178.08	138.34	104.08	59.87	57.45
Long-Term Investments	2.47	8.87	10	-	-	-
Other Intangible Assets	39.31	1.91	2.24	2.67	3.09	3.81
Long-Term Deferred Tax Assets	2.67	2.58	4.12	3.85	0.43	-
Long-Term Deferred Charges	-	36.29	34.22	36.59	21.03	4.37
Other Long-Term Assets	14.13	5.63	9.44	15.47	7.71	0.3
Total Assets	605.53	579.8	517.55	409.99	292.47	267.59

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	35.88	21.17	15.23	9.31	5.27	5.26
Accrued Expenses	-	12.03	22.8	38.8	27.96	43.21
Short-Term Debt	5.37	5.22	5.26	8.86	0.13	-
Current Portion of Long-Term Debt	48.28	32.33	43.31	11.04	11.19	-
Current Portion of Leases	3.39	5.92	6.18	4.23	4.01	4.61
Current Income Taxes Payable	0.9	0.87	2.41	2.18	3.11	1.72
Current Unearned Revenue	25.39	18.29	17.67	25.16	21.81	20.21
Other Current Liabilities	-	7.73	10.64	15.22	16.78	17.29
Total Current Liabilities	119.22	103.55	123.5	114.79	90.26	92.3
Long-Term Debt	30.31	55.51	56.01	30.61	-	-
Long-Term Leases	3.66	3.99	9.7	6.99	7.47	0.99
Long-Term Unearned Revenue	2.05	1.97	0.26	-	-	-
Long-Term Deferred Tax Liabilities	1.59	1.53	2.45	0.43	-	-
Total Liabilities	156.82	166.56	191.91	152.82	97.73	93.29

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	59.71	59.71	59.71	63.65	63.65	63.5
Additional Paid-In Capital	-	709.15	725.69	751.76	751.76	750.77
Retained Earnings	-	-437.21	-544.52	-628.48	-699.36	-737.87
Treasury Stock	-	-	-	-5.17	-	-
Comprehensive Income & Other	389	81.59	84.76	75.42	78.7	97.91
Shareholders' Equity	448.71	413.25	325.65	257.17	194.75	174.31
Total Liabilities & Equity	605.53	579.8	517.55	409.99	292.47	267.59

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	91.02	102.97	120.45	61.73	22.8	5.6
Net Cash (Debt)	11.29	84.71	53.63	79.87	85.82	84.73
Net Cash Growth	-85.98%	57.97%	-32.86%	-6.94%	1.29%	15.23%
Net Cash Per Share	0.00	0.01	0.01	0.01	0.01	0.01
Filing Date Shares Outstanding	5,994	5,971	5,971	6,279	6,365	6,350
Total Common Shares Outstanding	5,994	5,971	5,971	6,279	6,365	6,350
Working Capital	230.06	230.79	195.28	123.31	110.09	109.36
Book Value Per Share	0.07	0.07	0.05	0.04	0.03	0.03
Tangible Book Value	409.4	411.34	323.41	254.51	191.66	170.5
Tangible Book Value Per Share	0.07	0.07	0.05	0.04	0.03	0.03
Buildings	-	96.67	86.67	87.95	88.88	90.45
Machinery	-	187.2	160.98	118.54	117.24	127.38
Construction In Progress	-	63.62	41.11	54.56	5.81	2.09

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error